疏血通注射液治疗急性脑梗死患者的临床观察及其对血清C反应蛋白的影响

目的 探讨疏血通注射液治疗急性脑梗死患者的疗效及对血清C反应蛋白(CRP)的影响.方法 选择发病48 h内的急性脑梗死患者120例.按照随机数字表法分为治疗组和对照组(各60例),两组患者视病情轻重及并发症给予对症治疗,其中治疗组给予疏血通6mL静脉滴注,对照组给予安慰剂曲克芦丁入液静滴,每天1次,疗程均为14d.采用免疫散射速率比浊法测定两组患者治疗前及治疗后第5天、第10天、第14天血清CRP浓度,并观察两组患者治疗前及治疗后14d时临床神经功能缺损程度评分.结果治疗组治疗后第5天、第10天、第14天血清CRP浓度与对照组比较差异均有统计学意义(P<0.05).治疗组患者治疗后14 d时神经功能缺损评分为14.57±7.88,明显低于对照组(19.08±8.11),比较差异有统计学意义(P<0.05).结论 疏血通注射液有降低急性脑梗死患者血清CRP浓度、改善神经功能的作用.     

疏血通注射液治疗急性脑梗死患者的临床观察及其对血清C反应蛋白的影响

Objective To observe the curative effects of Shuxuetong in treating patients with acute cerebral infarction and its effects on the level of serum C-reactive protein (CRP).Methods One hundred and twenty patients with acute cerebral infarction who had the onset within 48 h were equally randomized into treatment group and control group.Six ml Shuxuetong and Troxerutin for intravenous drip daily were given to the treatment group and the control group,respectively,for a consecutive 14 d.The concentrations of serum CRP in the 2 groups were measured by immunonephelometry before treatment and on the 5th,10th and 14th d of treatment.The scores of neurological functional deficit scale were compared before treatment and on the 14th d of treatment in the 2 groups.Results The concentration of serum CRP in the treatment group on the 5th,10th and 14th d of treatment was significantly lower than that in the control group (P<0.05).The scores of neurological functional deficit scale in the treatment group (14.57±7.88) were significantly lower than those in the control group (19.08±8.11) (P<0.05).The clinical efficacy between the 2 groups was obviously different (P<0.05).Conclusion Shuxuetoug can decrease the concentration of serum CRP and improve the nervous function in patients with acute cerebral infarction.     

糖尿病合并低血糖致基底动脉尖综合征的临床分析

目的为了更进一步探讨糖尿病合并药源性低血糖对基底动脉尖综合征的影响。方法对32例中老年糖尿病合并低血糖致基底动脉尖综合征临床资料进行回顾性分析。结果糖尿病患者在应用过量胰岛素或口服磺脲类降糖药，而不及时监测血糖的情况下，引起低血糖反应，随即在长期糖尿病动脉硬化的基础上，低血糖又易导致基底动脉尖综合征的发生。结论糖尿病合并低血糖在基底动脉尖综合征中起重要作用，为预防并及时纠正低血糖引起并发症提供了依据。     

疏血通注射液治疗急性脑梗死患者的临床观察及其对血清C反应蛋白的影响

Objective To observe the curative effects of Shuxuetong in treating patients with acute cerebral infarction and its effects on the level of serum C-reactive protein (CRP).Methods One hundred and twenty patients with acute cerebral infarction who had the onset within 48 h were equally randomized into treatment group and control group.Six ml Shuxuetong and Troxerutin for intravenous drip daily were given to the treatment group and the control group,respectively,for a consecutive 14 d.The concentrations of serum CRP in the 2 groups were measured by immunonephelometry before treatment and on the 5th,10th and 14th d of treatment.The scores of neurological functional deficit scale were compared before treatment and on the 14th d of treatment in the 2 groups.Results The concentration of serum CRP in the treatment group on the 5th,10th and 14th d of treatment was significantly lower than that in the control group (P<0.05).The scores of neurological functional deficit scale in the treatment group (14.57±7.88) were significantly lower than those in the control group (19.08±8.11) (P<0.05).The clinical efficacy between the 2 groups was obviously different (P<0.05).Conclusion Shuxuetoug can decrease the concentration of serum CRP and improve the nervous function in patients with acute cerebral infarction.